Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 388 results found since Jan 2013.
Community screening for atrial fibrillation in the era of smart devices
Atrial fibrillation (AF) associated strokes can be effectively prevented by oral anticoagulant therapy, but patients often miss opportunities for adequate thromboprophylaxis due to lack of symptoms or electrocardiographic (ECG) documentation of AF. Early identification of AF has become an important issue not only from the healthcare perspective but also in the social aspect, given the burden of disabling stroke related to this common arrhythmia. The latest guidelines have therefore recommended the opportunistic screening for AF by pulse palpation or single ‑lead ECG in individuals aged>65 years or in individuals with ...
Source: International Journal of Cardiology - January 9, 2019 Category: Cardiology Authors: Seung Yong Shin, Gregory Y.H. Lip Tags: Editorial Source Type: research
Connecting atrial morphology with platelet reactivity: What the left atrial appendage can tell us about the procoagulant state in atrial fibrillation
Atrial fibrillation (AF) remains the most common form of heart rhythm disorder and a leading cause for stroke and mortality. A major challenge for comprehensive AF prevention and management is the timely identification and risk stratification of patients requiring treatment.
Source: International Journal of Cardiology - December 20, 2018 Category: Cardiology Authors: Anke C. Fender Tags: Editorial Source Type: research
Secondary stroke prevention in atrial fibrillation: Still lacking pace?
The high risk of recurrent stroke due to atrial fibrillation (AF) and the ominous outcome thereafter render secondary prevention with oral anticoagulation (OA) critical [1].
Source: International Journal of Cardiology - December 15, 2018 Category: Cardiology Authors: G.D. Athanassopoulos, I. Armenis Tags: Editorial Source Type: research
Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study
Early detection of Atrial Fibrillation (AF) is a public health priority across the globe because AF-related strokes are preventable. Despite an ongoing stroke epidemic in India, a public health strategy for AF screening and treatment is missing because the epidemiology of AF in India remains poorly defined.
Source: International Journal of Cardiology - December 5, 2018 Category: Cardiology Authors: Apurv Soni, Sunil Karna, Nisha Fahey, Saket Sanghai, Harshil Patil, Shyamsundar Raithatha, Sunil Thanvi, Somashekhar Nimbalkar, Ben Freedman, Jeroan Allison, David D. McManus Source Type: research
Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany
The goal of this study was to analyze the impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation (AF) patients followed in general practices in Germany.
Source: International Journal of Cardiology - December 1, 2018 Category: Cardiology Authors: Joachim R. Ehrlich, Christiane Look, Karel Kostev, Carsten W. Israel, Andreas Goette Source Type: research
Antithrombotic therapy after acute coronary syndromes in patients with atrial fibrillation: Shouldn't we pay more attention to the risk of ischemic and thromboembolic events?
The management of antithrombotic therapy in patients with atrial fibrillation (AF) presenting an acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) is particularly complex. Oral anticoagulation (OAC) is superior to single or dual antiplatelet therapy (DAPT) for the prevention of thromboembolic complications (stroke and systemic embolism) due to AF, whereas DAPT with low-dose aspirin and a P2Y12 inhibitor is the recommended antithrombotic treatment to prevent ischemic events (myocardial infarction and stent thrombosis) in patients with ACS or undergoing PCI.
Source: International Journal of Cardiology - November 29, 2018 Category: Cardiology Authors: Jos é Luis Ferreiro, Joan Antoni Gómez-Hospital Tags: Editorial Source Type: research
Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies
Persistent atrial fibrillation (AF) is associated with higher stroke and mortality risk than paroxysmal AF (pAF). Outcomes of catheter or surgical ablation are worse in patients with persistent AF than in pAF, and the optimal invasive rhythm control strategy has not been established.
Source: International Journal of Cardiology - November 29, 2018 Category: Cardiology Authors: Wouter R. Berger, Eva R. Meulendijks, Jacqueline Limpens, Nicoline W.E. van den Berg, Jolien Neefs, Antoine H.G. Driessen, S ébastien P.J. Krul, Wim Jan P. van Boven, Joris R. de Groot Source Type: research
Morphological determinators of platelet activation status in patients with atrial fibrillation
Stage of platelet activation is an important modulator of stroke risk associated with atrial fibrillation (AF). However, factors determining such activation status of thrombocytes in patients with AF are still not well studied.
Source: International Journal of Cardiology - November 17, 2018 Category: Cardiology Authors: Jedrzej Kosiuk, Tobias Uhe, Clara Stegmann, Laura Ueberham, Livio Bertagnolli, Nikolaos Dagres, Borislav Dinov, Andreas M üssigbrodt, Sergio Richter, Ingo Paetsch, Cosima Jahnke, Sebastian Hilbert, Philipp Sommer, Gerhard Hindricks, Andreas Bollmann Source Type: research
Impact of hospitalization in patients with atrial fibrillation: Implications for health-care providers and clinical management
For several years, stroke, thromboembolic events and oral anticoagulant (OAC) related major bleeding have been the most feared clinical events considered among atrial fibrillation (AF) [1]. Consequently, the most part of attention was drawn to optimization of OAC therapy to obtain a reduction of thromboembolic events keeping low the incidence of bleeding adverse events [1]. More recently, a lot of focus has been paid to other outcomes as hospitalization/rehospitalization [2], myocardial infarction [3] and death (both cardiovascular and all-cause death) [4].
Source: International Journal of Cardiology - October 23, 2018 Category: Cardiology Authors: Marco Proietti Tags: Editorial Source Type: research
Pulse rate variability predicts atrial fibrillation and cerebrovascular events in a large, population-based cohort
Many patients with atrial fibrillation (AF) present with stroke as their first clinical manifestation and since improved AF screening methods are thus required, we investigated whether pulse rate variability parameters predict future AF and cerebrovascular events.
Source: International Journal of Cardiology - October 9, 2018 Category: Cardiology Authors: John D. Sluyter, Carlos A. Camargo, Andrew Lowe, Robert K.R. Scragg Source Type: research
Stroke prevention in atrial fibrillation: State of the art
Stroke prevention is the cornerstone of the management of patients with atrial fibrillation (AF). Individual stroke risk stratification is generally the first step of deciding whether oral anticoagulation (OAC) will benefit patients with AF. Given that existing approaches to the prediction of ‘high risk’ subjects are of limited value, the initial focus should be the identification of ‘low-risk’ patients who do not need antithrombotic therapy. For this, the CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥ 75 [2 points], diabetes mellitus, previous stroke/tra nsient ischemic attack [2 points], ...
Source: International Journal of Cardiology - September 19, 2018 Category: Cardiology Authors: Yan-Guang Li, Gregory Y.H. Lip Tags: Review Source Type: research
New-onset atrial fibrillation in ICU: A FROG in the throat
We read with interest the recent paper by M. Arrigo et al. [1]. The authors provide for the first time prospective multicentre results on long-term prognosis of new-onset atrial fibrillation (NOAF) in critical illness patients, thus highlighting the need for a better understanding of the pathophysiological mechanisms involved. Indeed, although a major focus on stroke risk has been brought forward recently, heart failure events are one of the major determinants of the poor prognosis carried by AF patients in the general population as well as in post-ICU one's.
Source: International Journal of Cardiology - September 13, 2018 Category: Cardiology Authors: Charles Guenancia, Auguste Dargent, Audrey Large, Pascal Andreu, Jean-Pierre Quenot Tags: Letter to the Editor Source Type: research
Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice
Guidelines on atrial fibrillation (AF) recommend the CHA2DS2-VASc rule for anticoagulant decision-making, but underuse exists. We studied the impact of an automated decision support on stroke prevention in patients with AF in a cluster randomised trial in general practice.
Source: International Journal of Cardiology - September 7, 2018 Category: Cardiology Authors: S. van Doorn, F.H. Rutten, C.M. O'Flynn, R. Oudega, A.W. Hoes, K.G.M. Moons, G.J. Geersing Source Type: research
One-year risks of stroke and death in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
Differences exist in oral anticoagulation (OAC) use between different populations with atrial fibrillation (AF), which may be associated with varying outcomes.
Source: International Journal of Cardiology - September 1, 2018 Category: Cardiology Authors: Yan-Guang Li, Kazuo Miyazawa, Andreas Wolff, Mohammad Zubaid, Alawi A. Alsheikh-Ali, Kadhim Sulaiman, Gregory Y.H. Lip Source Type: research
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
Differences exist in oral anticoagulation (OAC) use between different populations with atrial fibrillation (AF), which may be associated with varying outcomes.
Source: International Journal of Cardiology - September 1, 2018 Category: Cardiology Authors: Yan-Guang Li, Kazuo Miyazawa, Andreas Wolff, Mohammad Zubaid, Alawi A. Alsheikh-Ali, Kadhim Sulaiman, Gregory Y.H. Lip Source Type: research
